Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritis.
axial SpA
feasibility
fibromyalgia
telephone-based cognitive behavioural therapy
Journal
Rheumatology advances in practice
ISSN: 2514-1775
Titre abrégé: Rheumatol Adv Pract
Pays: England
ID NLM: 101736676
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
07
2020
revised:
08
10
2020
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
The aim was to assess the feasibility and acceptability of a telephone-based cognitive behaviour therapy (tCBT) intervention for individuals with axial SpA (axSpA), with and without co-morbid FM, and to measure the change in patient-reported health outcomes. A convenience sample of individuals recruited from British Society for Rheumatology Biologics Registry for AS (BSRBR-AS) sites were offered a course of tCBT (framed as coaching). Patient-reported outcomes were measured at baseline and on course completion. Semi-structured qualitative interviews assessed intervention acceptability. Thematic analysis was informed by the theoretical framework of acceptability. Forty-two participants attended for initial assessment. Those completing at least one tCBT session ( Higher uptake among axSpA patients with co-morbid FM suggests that these individuals have additional needs. The findings are helpful in identifying patients most likely to engage with and benefit from tCBT and to maximize participation.
Identifiants
pubmed: 34222775
doi: 10.1093/rap/rkaa063
pii: rkaa063
pmc: PMC8248414
doi:
Types de publication
Journal Article
Langues
eng
Pagination
rkaa063Subventions
Organisme : Versus Arthritis
ID : 21378
Pays : United Kingdom
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
J Rheumatol. 1994 Dec;21(12):2286-91
pubmed: 7699630
Ann Rheum Dis. 2020 Aug;79(8):1055-1062
pubmed: 32522742
Rheumatology (Oxford). 2019 Oct 1;58(10):1746-1754
pubmed: 31220322
J Rheumatol. 1994 Dec;21(12):2281-5
pubmed: 7699629
J Rheumatol. 2011 Jun;38(6):1113-22
pubmed: 21285161
Arthritis Rheumatol. 2017 Nov;69(11):2144-2150
pubmed: 28622461
RMD Open. 2015 Feb 18;1(1):e000026
pubmed: 26509056
BMC Musculoskelet Disord. 2012 Dec 10;13:243
pubmed: 23227937
J Clin Epidemiol. 1988;41(4):313-21
pubmed: 3351539
J Psychosom Res. 1993;37(2):147-53
pubmed: 8463991
JAMA. 2012 Jun 6;307(21):2278-85
pubmed: 22706833
Arch Intern Med. 2012 Jan 9;172(1):48-57
pubmed: 22082706
Rheumatology (Oxford). 2018 Nov 1;57(11):1982-1990
pubmed: 30053166
BMC Rheumatol. 2019 May 20;3:19
pubmed: 31143851
Cochrane Database Syst Rev. 2013 Sep 10;(9):CD009796
pubmed: 24018611
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Rheumatol. 2016 Nov;43(11):2056-2063
pubmed: 27633820
Ann Rheum Dis. 2003 Jan;62(1):20-6
pubmed: 12480664
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Rheumatology (Oxford). 2018 Aug 1;57(8):1453-1460
pubmed: 29788461
J Eval Clin Pract. 2004 May;10(2):307-12
pubmed: 15189396
Arthritis Res Ther. 2016 Feb 09;18:42
pubmed: 26860612
Cognit Ther Res. 2012 Oct 1;36(5):427-440
pubmed: 23459093
Ann Rheum Dis. 2018 Apr;77(4):533-540
pubmed: 29183878
BMC Musculoskelet Disord. 2019 May 10;20(1):198
pubmed: 31077168
BMC Musculoskelet Disord. 2016 Aug 22;17(1):354
pubmed: 27549811